Core Viewpoint - Fujian Wancheng Biotechnology Group Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CICC and China Merchants Securities International as joint sponsors [1] Company Overview - Wancheng Group is recognized as one of China's leading and fastest-growing scale snack and beverage retail enterprises, with a projected GMV growth of 282% from 2023 to 2024 [3] - The company's national brand "Haoxianglai" is expected to rank first in China's snack and beverage retail brand list by GMV in 2024 and is the first retail brand to exceed 10,000 stores nationwide [3] - By June 30, 2025, the store network is anticipated to surpass 15,000 locations, covering 29 provinces, municipalities, and autonomous regions in China, establishing a significant leading position in economically developed areas and populous provinces [3] Supply Chain and Pricing Strategy - Approximately 95% of Wancheng Group's products are sourced directly from brand manufacturers, utilizing 51 ambient warehouses and 13 cold chain warehouses for distribution [3] - This model allows the company to offer prices that are 20-30% lower than similar products in large supermarkets and convenience stores, while maintaining healthy profit margins for franchise partners [3] Market Potential - The Chinese hard discount retail market is projected to reach RMB 1,013.8 billion by 2029, with a compound annual growth rate (CAGR) of 33.8% from 2024 to 2029 [6] Product Offering - Wancheng Group's product portfolio includes twelve core categories, such as bottled water, dairy products, meat snacks, and baked goods, with over 4,000 SKUs selected from a vast range [6] - Each store typically stocks about 1,800-2,000 SKUs, with an average of 250 new SKUs launched monthly in the first half of 2025, while regularly phasing out underperforming SKUs to maintain product freshness and operational efficiency [6] Financial Performance - The company reported revenues of approximately RMB 549.3 million, RMB 9.29 billion, RMB 32.33 billion, and RMB 22.58 billion for the fiscal years ending December 31 for 2022, 2023, 2024, and the six months ending June 30, 2025, respectively [7] - Profit figures for the same periods were approximately RMB 67.85 million, -RMB 176.21 million, RMB 610.91 million, and RMB 860.50 million [7]

Core Viewpoint - Wancheng Group (万辰集团) has submitted an application for listing on the Hong Kong Stock Exchange, with CICC and China Merchants Securities International as joint sponsors. The company is recognized as a leading and fastest-growing retail enterprise in China's snack and beverage sector, with significant growth projections for the coming years [1][4]. Company Overview - Wancheng Group is identified as one of China's leading and fastest-growing retail enterprises in the snack and beverage sector, with a projected GMV growth of 282% from 2023 to 2024 [4]. - The company's brand "Haoxianglai" is expected to rank first in China's snack and beverage retail brand list by GMV in 2024 and has surpassed 10,000 stores nationwide, making it the first retail brand in this category to achieve such a milestone [4]. - By June 30, 2025, Wancheng Group's store network is anticipated to exceed 15,000 locations, covering 29 provinces, municipalities, and autonomous regions in China, establishing a strong presence in economically developed areas and populous provinces [4]. Supply Chain and Pricing Strategy - Approximately 95% of Wancheng Group's products are sourced directly from brand manufacturers, utilizing a distribution network of 51 ambient warehouses and 13 cold chain warehouses [4]. - This sourcing model allows the company to offer prices that are 20-30% lower than similar products in large supermarkets and convenience stores, while maintaining healthy profit margins for both the company and its franchise partners [4]. Market Potential - The Chinese hard discount retail market is projected to reach a market size of RMB 1,013.8 billion by 2029, with a compound annual growth rate (CAGR) of 33.8% from 2024 to 2029 [6]. - Wancheng Group's product portfolio includes twelve core categories, with over 4,000 SKUs selected from a vast array, and each store typically stocks about 1,800-2,000 SKUs [6]. Financial Performance - The company reported revenues of approximately RMB 549.3 million, RMB 9.29 billion, RMB 32.33 billion, and RMB 22.58 billion for the fiscal years ending in 2022, 2023, 2024, and the six months ending June 30, 2025, respectively [6][7]. - Profit figures for the same periods were approximately RMB 67.85 million, -RMB 176.21 million, RMB 610.91 million, and RMB 860.50 million [6][7].

Core Viewpoint - Fujian Wancheng Biotechnology Group Co., Ltd. (Wancheng Group) has submitted its listing application to the Hong Kong Stock Exchange, aiming for a main board listing, highlighting its rapid growth and leading position in China's snack and beverage retail market [2][4]. Financial Performance - Wancheng Group's total revenue is projected to grow from RMB 9.3 billion in 2023 to RMB 32.3 billion in 2024, representing a year-on-year increase of 247.9% [4]. - The group's GMV is expected to reach RMB 42.6 billion in 2024, a growth of 282% compared to 2023, leading the industry in growth rate [4]. - For the first half of 2025, the group reported revenue of RMB 22.58 billion, a year-on-year increase of 106.9%, with adjusted net profit reaching RMB 920 million [5]. Business Model and Growth Strategy - Wancheng Group's growth is driven by a "growth flywheel" consisting of five key elements, which is central to its business strategy and ensures a win-win situation for consumers, franchisees, suppliers, and the company [6][8]. - The expansion of the store network enhances procurement scale, improving bargaining power with suppliers, which allows the company to offer high-quality products at competitive prices [8]. Competitive Advantages - As of June 30, 2025, Wancheng Group operates over 15,000 stores across 29 provinces, establishing a significant scale advantage and deep market penetration, particularly in high-consumption areas [9]. - The company has streamlined its supply chain, achieving approximately 95% direct procurement from brand manufacturers, which allows for a cost advantage passed on to consumers [9]. User Engagement and Marketing - Wancheng Group has built a robust user ecosystem with over 150 million registered members, with active members contributing approximately 78% of the group's GMV [11][13]. - The company employs a combination of private domain user engagement and public domain marketing strategies, including celebrity endorsements and collaborations with popular IPs, to enhance brand visibility and consumer interaction [10][14]. Future Outlook - The funds raised from the IPO will be used to further expand and upgrade the store network, enrich product offerings, enhance logistics efficiency, and upgrade digital infrastructure [14]. - With the support of capital, Wancheng Group aims to solidify its leadership in the Chinese snack and beverage retail sector and expand its successful discount model into broader FMCG markets [14].

香港聯合交易所有限公司與證券及期貨事務監察委員會對本申請版本的內容概不負責，對其準確性或完整 性亦不發表任何意見，並明確表示概不就因本申請版本全部或任何部分內容而產生或因倚賴該等內容而引 致的任何損失承擔任何責任。 FUJIAN WANCHEN BIOTECHNOLOGY GROUP CO., LTD. 福建萬辰生物科技集團股份有限公司 （「本公司」） （於中華人民共和國註冊成立的股份有限公司） 的申請版本 警告 本申請版本乃根據香港聯合交易所有限公司（「聯交所」）與證券及期貨事務監察委員會（「證監會」）的要求 而刊發，僅用作提供資訊予香港公眾人士。 本申請版本為草擬本，其內所載資料並不完整，亦可能會作出重大變動。 閣下閱覽本文件，即代表 閣 下知悉、接納並向本公司、其保薦人、整體協調人、顧問或包銷團成員表示同意： 本公司招股章程根據香港法例第32章公司（清盤及雜項條文）條例與香港公司註冊處處長登記前，本公司 不會向香港公眾人士提出要約或邀請。倘於適當時候向香港公眾人士提出要約或邀請，有意投資者務請僅 依據呈交香港公司註冊處註冊的本公司招股章程作出投資決定；有關文本將於發售期內向公眾刊發。 (a) 本文件僅為 ...